NY Blood Thinner Injury Lawyers | Eliquis®, Pradaxa®, and Xarelto®
Claims have been made that Pfizer and Bristol-Myres Squibb failed to disclose material information to the Food and Drug Administration (FDA) concerning these drugs, commonly known as “Eliquis®”. Eliquis® is marketed as an anticoagulant, meaning that it decreases the process for blood clotting through inhibiting Factor Xa.
Because there has been no known reversal agent which would allow for normal blood clotting, patients using Eliquis® may be at a high risk of bleeding to death during surgery, as well as other complications that may arise when blood does not clot normally. We are part of the Blood Thinner Litigation Group, which is devoted to helping those injured, and the families who have lost a loved one, due to the use of Eliquis®, Pradaxa®, and Xarelto®.
Blood Thinner Litigation Website
We invite you to see the website for the Blood Thinner Litigation Group, and to call us to learn how we can help. We offer a free consultation, and there are no fees for us unless and until we recover for you.